Related content

Tuesday 10 February 2004 at the National Heart & Lung Institute, London

By  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 2, 2004-01 ,pp. : 115-123

Adis International

Access to resources Recommend Favorite

The New Unified International Diabetes Federation/American Heart Association/National Heart, Lung, and Blood Institute Metabolic Syndrome Definition: Does It Correlate Better with C-reactive Protein in Chinese Patients Diagnosed with Type 2 Diabetes?

By Lu B   Zhang S   Wen J   Yang Y   Yang Z   Zhang Z   Wang X   Hu R  

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 1923-1932

Field House Publishing

Access to resources Recommend Favorite

Gender Research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A Summary of Findings

By Greenfield Shelly F.   Rosa Carmen   Putnins Susan I.   Green Carla A.   Brooks Audrey J.   Calsyn Donald A.   Cohen Lisa R.   Erickson Sarah   Gordon Susan M.   Haynes Louise   Killeen Therese   Miele Gloria   Tross Susan   Winhusen Theresa  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite

According to The British Society for Rheumatology guidelines, 5.6% of outpatients with rheumatoid arthritis (RA) in the West Midlands, UK, are eligible for anti-tumour necrosis factor (TNF) monoclonal antibody therapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

72nd Meeting of the American Heart Association

By Lunnon M.W.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 581-587

Informa Healthcare

Access to resources Recommend Favorite